drugset / Trial / NCT03819010
Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an international, multicenter, open-label, non-comparative, Simon´s two-stage design, phase II clinical trial.
Timeline
- Start
- 2019-05-07
- Primary completion
- 2019-07-30
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Letrozole | Other / unclassified | 2.5 mg | — |
| Comparator | Palbociclib | Small molecule | 125 mg | — |